120277-73-8 Usage
General Description
3-(2-Bromoethyl) pyridine is a chemical compound with the molecular formula C7H8BrN. It is a derivative of pyridine, a six-membered heterocyclic ring containing a nitrogen atom. The characteristic feature of 3-(2-Bromoethyl) pyridine is the presence of a bromoethyl group attached to the pyridine ring, which makes it useful in organic synthesis and pharmaceutical research. 3-(2-BROMOETHYL) PYRIDINE is commonly used as a building block in the synthesis of complex organic molecules and pharmaceuticals due to its reactivity and potential for forming new chemical bonds. It is also known for its role as an intermediate in the production of various pharmaceutical agents and agrochemicals. Due to its potential reactivity and properties, 3-(2-Bromoethyl) pyridine is carefully handled and used in controlled environments by trained professionals.
Check Digit Verification of cas no
The CAS Registry Mumber 120277-73-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,2,7 and 7 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 120277-73:
(8*1)+(7*2)+(6*0)+(5*2)+(4*7)+(3*7)+(2*7)+(1*3)=98
98 % 10 = 8
So 120277-73-8 is a valid CAS Registry Number.
120277-73-8Relevant articles and documents
Pyrimidine derivatives useful as inhibitors of PKC-theta
-
Page/Page column 101, (2008/06/13)
Disclosed are novel compounds of formula (I): wherein X, Y, R1, R2 and R3 are as defined herein, which are useful as inhibitors of PKC-theta and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC-theta, including immunological disorders and type II diabetes. This invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.